Ansiling, Baby Girl .
HRN: 26-09-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/30/2024
11/06/2024
IV
32mg
Q8
PSNB; TC Neonatal Tetanus
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamCentral Nervous SystemProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes